Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

THR

Thermon (THR)

Thermon Group Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:THR
DateHeureSourceTitreSymboleSociété
16/05/202421h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:THRThermon Group Holdings Inc
15/05/202422h01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:THRThermon Group Holdings Inc
11/03/202418h14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:THRThermon Group Holdings Inc
14/02/202416h04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:THRThermon Group Holdings Inc
01/02/202423h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:THRThermon Group Holdings Inc
01/02/202416h27Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:THRThermon Group Holdings Inc
01/02/202412h45Edgar (US Regulatory)Form 8-K - Current reportNYSE:THRThermon Group Holdings Inc
21/06/202316h25Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:THRThermon Group Holdings Inc
21/06/202316h23Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:THRThermon Group Holdings Inc
05/06/202321h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:THRThermon Group Holdings Inc
31/05/202321h17Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:THRThermon Group Holdings Inc
25/05/202312h45Edgar (US Regulatory)Current Report Filing (8-k)NYSE:THRThermon Group Holdings Inc
14/02/202322h11Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:THRThermon Group Holdings Inc
09/02/202318h07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:THRThermon Group Holdings Inc
06/02/202320h59Edgar (US Regulatory)Schedule 13g
(sc 13g/a)
NYSE:THRThermon Group Holdings Inc
03/11/202217h02Edgar (US Regulatory)Quarterly Report (10-q)NYSE:THRThermon Group Holdings Inc
26/05/202222h02Edgar (US Regulatory)Annual Report (10-k)NYSE:THRThermon Group Holdings Inc
23/02/202217h43Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:THRThermon Group Holdings Inc
04/02/202215h26Edgar (US Regulatory)Schedule 13gNYSE:THRThermon Group Holdings Inc
27/05/202123h14Edgar (US Regulatory)Amended Annual Report (10-k/a)NYSE:THRThermon Group Holdings Inc
09/04/202122h10Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NYSE:THRThermon Group Holdings Inc
18/11/202012h04Edgar (US Regulatory)Notice of Effectiveness (effect)NYSE:THRThermon Group Holdings Inc
27/07/202023h23Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:THRThermon Group Holdings Inc
11/06/201907h30GlobeNewswireONCURIOUS NV Receives Project Grant from VLAIO to Progress its Pipeline of Next Generation Cancer ImmunotherapiesNYSE:THRThermon Group Holdings Inc
06/06/201919h00GlobeNewswireOxurion NV - Data from a Phase 1/2 Clinical Study evaluating THR-317 (anti-PlGF) for DME presented at 2019 FLORetina MeetingNYSE:THRThermon Group Holdings Inc
30/05/201921h12Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NYSE:THRThermon Group Holdings Inc
08/05/201907h30GlobeNewswireOxurion NV : Oxurion NV Business Update - Q1 2019NYSE:THRThermon Group Holdings Inc
24/04/201907h30GlobeNewswireOxurion NV announces full enrollment in its Phase 1 trial evaluating the safety of its plasma kallikrein inhibitor THR-149 fo...NYSE:THRThermon Group Holdings Inc
04/04/201907h30GlobeNewswireOxurion NV announces full enrollment of its Phase 2 trial evaluating efficacy and safety of the combination of anti-PlGF (THR...NYSE:THRThermon Group Holdings Inc
07/03/201917h45GlobeNewswireOxurion NV Business Update - FY 2018NYSE:THRThermon Group Holdings Inc
 Showing the most relevant articles for your search:NYSE:THR